Related Experiment Video
Updated: May 17, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
[Opiates, harm reduction and polysubstance abuse]
Didier Touzeau1, Pascal Courty
1Groupe hospitalier Paul-Guiraud, pôle addictions clinique Liberté, 92220 Bagneux, France. didier.touzeau@ch-pgv.fr
Abstract:
Opioid dependence is a chronic metabolic brain disease and several individual, sociological and biological factors are implicated in its development. Program (needle exchange, low threshold access to treatment) prevent harms associated with opioid use (HIV, overdose…). Effective treatment involves a set of pharmacological and psychosocial interventions. The benefits of maintenance programmes increase as long as the person remains in treatment (many years). Relapse is a symptom of the disorder or a sign of abstinence failure. Treatment aims to improve quality of life in a comprehensive and individualised assessment.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Abuse and Addiction: Pharmacological Phenomena
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Dependence
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners

